Document Detail

Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001-2006).
MedLine Citation:
PMID:  22169049     Owner:  NLM     Status:  Publisher    
BACKGROUND: Owing to the paucity of evidence available on the risks and benefits of drug use in pregnancy, the use of prescription medicines is a concern for both pregnant women and their health care providers. OBJECTIVE: The aim of this study was to measure the frequency, timing, and type of medicines used before, during, and after pregnancy in a Canadian population. METHODS: This retrospective cohort analysis used population-based health care data from all pregnancies ending in live births in hospitals in British Columbia from April 2001 to June 2006 (n = 163,082). Data from hospital records were linked to those in outpatient prescription-drug claims. Data from prescriptions filled from 6 months before pregnancy to 6 months postpartum were analyzed. Drugs were classified by therapeutic category and US Food and Drug Administration (FDA) pregnancy risk categories. RESULTS: Prescriptions were filled in 63.5% of pregnancies. Evidence on safety is limited for many of the medicines most frequently filled in pregnancy, including codeine, salbutamol, and betamethasone. At least 1 prescription for a category D or X medicine was filled in 7.8% of pregnancies (5.5% category D; 2.5% category X). The most frequently filled prescriptions for category D drugs were benzodiazepines and antidepressants. The most frequently filled prescriptions for category X drugs were oral contraceptives and ovulation stimulants filled in the first trimester. CONCLUSIONS: The majority of pregnant women in British Columbia filled at least 1 prescription, and ∼1 in 13 filled a prescription for a drug categorized as D or X by the FDA. The prevalence of maternal prescription drug use emphasizes the need for postmarketing evaluation of the risk-benefit profiles of pharmaceuticals in pregnancy. Future research on prenatal drug use based on administrative databases should examine maternal treatment adherence and the determinants of maternal drug use, considering maternal health status, sociodemographics, and the characteristics and providers of prenatal care.
Jamie R Daw; Barbara Mintzes; Michael R Law; Gillian E Hanley; Steven G Morgan
Related Documents :
22258499 - Effects of cumulus cells on vitreous cryopreservation of human mature oocytes and clini...
21931749 - Maternal malaria, birth size and blood pressure in nigerian newborns: insights into the...
21627419 - Retrospective investigation of sudden maternal weight loss as an indicator of impending...
21938509 - Major depressive disorder during pregnancy and emotional attachment to the fetus.
3839699 - Histochemical demonstration of ornithine transcarbamylase activity in fetal liver.
22207319 - Adolescent pregnancy is associated with osteoporosis in postmenopausal women.
23249469 - Maternofetal consequences of coxiella burnetii infection in pregnancy: a case series of...
990219 - Cellular development of some embryonic organs and the chorion during the first trimeste...
11291789 - Nutrition in pregnancy and lactation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-12
Journal Detail:
Title:  Clinical therapeutics     Volume:  -     ISSN:  1879-114X     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier HS Journals, Inc. All rights reserved.
Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The ciliary transitional zone and nephrocystins.
Next Document:  Assessment of the efficacy and safety profiles of aspirin and acetaminophen with codeine: results fr...